Content uploaded by Domenic A Ciraulo
Author content
All content in this area was uploaded by Domenic A Ciraulo
Content may be subject to copyright.
Original Article
Effects of Yoga Versus Walking on Mood,
Anxiety, and Brain GABA Levels:
A Randomized Controlled MRS Study
Chris C. Streeter, MD,
1
Theodore H. Whitfield, ScD,
2
Liz Owen, BArch,
3
Tasha Rein, BA,
1
Surya K. Karri, MD, MPH,
4
Aleksandra Yakhkind, MS,
5
Ruth Perlmutter, MA,
6
Andrew Prescot, PhD,
7
Perry F. Renshaw, MD, PhD,
8
Domenic A. Ciraulo, MD,
1
and J. Eric Jensen, PhD
9
Abstract
Objectives: Yoga and exercise have beneficial effects on mood and anxiety. g-Aminobutyric acid (GABA)-ergic
activity is reduced in mood and anxiety disorders. The practice of yoga postures is associated with increased
brain GABA levels. This study addresses the question of whether changes in mood, anxiety, and GABA levels
are specific to yoga or related to physical activity.
Methods: Healthy subjects with no significant medical/psychiatric disorders were randomized to yoga or a
metabolically matched walking intervention for 60 minutes 3 times a week for 12 weeks. Mood and anxiety
scales were taken at weeks 0, 4, 8, 12, and before each magnetic resonance spectroscopy scan. Scan 1 was at
baseline. Scan 2, obtained after the 12-week intervention, was followed by a 60-minute yoga or walking inter-
vention, which was immediately followed by Scan 3.
Results: The yoga subjects (n¼19) reported greater improvement in mood and greater decreases in anxiety than
the walking group (n¼15). There were positive correlations between improved mood and decreased anxiety
and thalamic GABA levels. The yoga group had positive correlations between changes in mood scales and
changes in GABA levels.
Conclusions: The 12-week yoga intervention was associated with greater improvements in mood and anxiety
than a metabolically matched walking exercise. This is the first study to demonstrate that increased thalamic
GABA levels are associated with improved mood and decreased anxiety. It is also the first time that a behavioral
intervention (i.e., yoga postures) has been associated with a positive correlation between acute increases in
thalamic GABA levels and improvements in mood and anxiety scales. Given that pharmacologic agents that
increase the activity of the GABA system are prescribed to improve mood and decrease anxiety, the reported
correlations are in the expected direction. The possible role of GABA in mediating the beneficial effects of yoga
on mood and anxiety warrants further study.
Introduction
Yoga has been used to reduce symptoms of depres-
sion, anxiety, and epilepsy.
1–3
Reduced activity in
g-aminobutyric acid (GABA) systems has been found in mood
disorders, anxiety disorders, and epilepsy.
4–6
All three of
these conditions respond to pharmacologic agents known to
increase GABA system activity, raising the possibility that
some of the therapeutic effect may be via increased GABA
activity.
7
In a previous study using magnetic resonance
spectroscopy (MRS) to obtain brain GABA levels, our group
demonstrated that experienced yoga practitioners had a sig-
nificant (27%) increase in whole-slab GABA levels after a 60-
minute session of yoga postures compared to no change in
1
Division of Psychiatry, Boston University School of Medicine, Boston, MA.
2
Division of Actuarial Science, Boston University, Boston, MA.
3
Liz Owen Yoga, Arlington, MA.
4
Department of Neurosurgery, Harvard University, Boston, MA.
5
Medicine/Hematology-Oncology, Children’s Hospital Boston, Boston, MA.
6
School of Medicine, University of Massachusetts, Boston, MA.
7
Departments of Radiology and
8
Psychiatry, University of Utah, Salt Lake City, UT.
9
Department of Psychiatry, Harvard University, Belmont, MA.
This article was previously presented as a poster at the American Psychiatric Association Annual Meeting, San Francisco, CA in 2008.
THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE
Volume 16, Number 11, 2010, pp. 1–8
ªMary Ann Liebert, Inc.
DOI: 10.1089/acm.2010.0007
1
GABA levels in controls after a 60-minute reading session.
8
These findings raise the question of whether the associated
increase in GABA levels was specific to yoga or related to
physical activity in general.
There is a large body of research on the beneficial effects of
exercise on depression and anxiety.
2,9,10
The results of exer-
cise as a treatment for mild to moderate depression compare
favorably to psychotherapy and pharmacologic treatment,
supporting the contention that a behavioral intervention can
have an effect similar to a pharmacologic intervention on
mood.
11
This study extends the findings of self-reported mood
changes by exploring a possible mechanism: changes in
thalamic GABA levels measured on MRS. This study was
designed to correlate changes in mood, anxiety, and brain
GABA levels, and to determine whether such changes are
specific to a practice of yoga postures or whether they occur
in a metabolically matched walking intervention. We hy-
pothesize that improvement in mood scores correlate posi-
tively with GABA levels, while anxiety scores will correlate
negatively with GABA levels.
Materials and Methods
Subjects were recruited from the community by newspa-
per ads, flyers, and the Internet. Screening interviews and
written informed consent were obtained at Boston University
School of Medicine General Clinical Research Unit. Eligible
subjects were randomized in permuted blocks (n¼4) to a 12-
week intervention of either Iyengar yoga or walking for three
60-minute sessions per week, with a maximum of 36 ses-
sions. All subjects had three MRS scans: Scan 1 at baseline;
Scan 2 after their 12-week intervention; immediately after
Scan 2, all subjects completed a 60-minute yoga or walking
intervention, depending on group assignment, which was
immediately followed by Scan 3.
Participants were 18–45 years old with no current Axis I
diagnosis. Nonpsychoactive medications were allowed if the
subject had been on a stable dose for at least 1 month with no
anticipated changes during the study. The following items
were exclusionary: any yoga practice in the previous 3
months, or a lifetime history of one yoga session/week for
4 weeks; current participation in psychotherapy, prayer
groups, or any mind–body disciplines; a neurological dis-
order or medical condition that would compromise subject
safety or scan data; treatment within the previous 3 months
with medications that might affect the GABA system; use of
tobacco products (known to affect GABA levels)
12
; alcohol
consumption >4 drinks/day; and contraindication to mag-
netic resonance evaluation.
The following instruments were used for screening: the
Structured Clinical Interview for Diagnostic and Statistical
Manual of Mental Disorders IV to identify Axis I Disorders
13
and the Time Line Follow Back to assess alcohol consump-
tion.
14,15
Two (2) reliable and valid psychologic scales were
selected to monitor the effects of the interventions on mood
and anxiety over time. Mood was assessed with the Exercise-
Induced Feeling Inventory (EIFI), which has four subscales:
Positive Engagement, Revitalization, Tranquility, and Phy-
sical Exhaustion.
16
Anxiety was assessed with the State scale
of the Spielberger State–Trait Anxiety Inventory (STAI).
17
The EIFI and STAI-State were given before each scan, prior
to the first intervention session (week 0), and after comple-
tion of sessions at weeks 4, 8, and 12.
Metabolic equivalents (METs) are used to rate and com-
pare the physical demands of various activities.
18
The
American College of Sports Medicine list of metabolic
equivalents was consulted to match the 60-minute Iyengar
yoga intervention with a 60-minute walking intervention at
2.5 miles per hour (mph) on a flat surface rated at 3.0 METs.
During the intervention, the Physical Activity Recall (PAR), a
valid and widely used instrument, was used to convert each
subject’s weekly physical activity outside of the intervention
into a METs score.
19,20
For each group, the mean weekly PAR
METs scores was computed.
Certified Iyengar yoga instructors taught the yoga inter-
ventions, which were monitored by the Principal Investigator
to ensure consistency in presentation of weekly posture se-
quences. Written lists of the weekly sequences and pictures of
the postures were given to the subjects.
21
After 4 weeks of
instruction, subjects were encouraged to practice at home. The
intrascan yoga sequence was taught in class and monitored by
research staff during Imaging Session II. The structure of the
walking intervention was designed to be similar to that of the
yoga intervention, with weekly group sessions in which
subjects walked around the gym perimeter at 2.5 mph for
60 minutes. The intrascan walking session was done on a
treadmill set to 2.5 mph with 0 incline. This design controlled
for group effects and interaction time with research staff.
Imaging
Subjects were scanned on a 4-Tesla full-body MR scanner
(Varian/UnityInova, Varian Inc., Palo Alto, CA) at Mclean
Hospital in Belmont, MA. Scout images confirmed optimal
positioning. After global shimming on unsuppressed water,
T1-weighted anatomical images were taken in sagittal and
axial planes [echo time (TE)/repetition time (TR) ¼6.2 sec-
onds/11.4 milliseconds, field-of-view ¼22228 cm (sagittal)
and 222216 cm (axial), readout duration ¼4 ms, receive
bandwidth ¼32 kHz, in-plane matrix size ¼12825616
(sagittal) and 25625664 (axial), in-plane resolution ¼
0.941.9 mm (sagittal) and 0.940.94 mm (axial), readout
points ¼512, slice-thickness ¼2.5 mm, flip-angle ¼118].
In our previous study, a post-hoc regional analysis that
used multivoxel spectroscopic imaging showed that the
greatest increase in GABA levels after the yoga intervention
was in the thalamus.
8
The selection of the left thalamus was
based on evidence that the left side has greater parasympa-
thetic innervations and that GABA levels are lower in the left
thalamus in post-traumatic stress disorder subjects.
22,23
For
this study, an algorithm was developed to position a 223-
cm voxel over the left thalamus. Proton spectroscopy
implemented a MEGAPRESS [MEscher-GArwood Point-
Resolved Echo Spectroscopy Sequence] difference-editing
sequence specifically tuned for GABA.
24
Manual voxel
shimming yielded global water-line widths ranging from 8 to
15 Hz. The MEGAPRESS sequence collected 68-millisecond
echo-time spectra in an interleaved fashion where the GABA
editing pulse was applied on every second transient. Addi-
tional MEGAPRESS acquisition parameters were: TR¼2sec-
onds, spectral-bandwidth ¼2 kHz, readout-duration ¼512
milliseconds, Number of Excitations (NEX) ¼384, and total
scan duration ¼13 minutes.
2 STREETER ET AL.
In order to quantify GABA, the difference-edited spectra
were processed and then fitted with LCModel using basis sets
acquired at 4 T. A separate LCModel template was used to fit
the unedited 68-milisecond subspectrum to obtain creatine
(Cr). All fitted metabolite areas were normalized to the fitted
Cr resonance from the 68-millisecond subspectrum. One (1)
spectrum from the MEGAPRESS acquisition in the thalamus
was excluded from analysis due to low signal-to-noise.
GABA/Cr ratios are referred to as GABA levels. In order to
ascertain the gray and white matter contribution to each
voxel, the axial T
1
-weighted images were segmented into gray
matter, white matter, and cerebrospinal fluid compartments
using the commercial software package FSL 4.1 (FMRIB
Software Library; Analysis Group, FMRIB; Oxford, UK).
Statistical analysis
The primary outcome variables were mood scores, anxiety
scores, and thalamic GABA levels. Continuous measures
were summarized by means standard deviations; within-
group comparisons were performed using paired t-tests,
while between-group comparisons were performed using
two-sample t-tests. Discrete measures were summarized by
raw counts for numerators and denominators, as well as the
associated percentages, and were compared by Fisher’s exact
test due to the limited sample size. Linear regression analysis
was used to quantify the association between the primary
outcome variables and potential predictor variables. In order
to take into account within-subject correlations arising from
repeated longitudinal measurements, generalized estimated
equations (GEEs) were used to analyze within-group trends
in mood and anxiety scores, as well as to perform between-
group analyses.
25,26
All hypothesis tests were two-tailed and
conducted at the a¼0.05 significance level. Confidence in-
tervals were two-sided and were constructed with 95% con-
fidence. Stata 10.0 (College Station, TX) was used for analysis.
Results
Demographics and study participation
Thirty-four (34) subjects completed the study: 19 in the
yoga group and 15 in the walking group (Fig. 1). There was
no significant difference between groups for demographic or
descriptive variables except for height, which although sta-
tistically significant due to a relatively small standard devi-
ation was clinically not significant. There was no difference
in demographics between study completers and dropouts,
Table 1. Demographics and Study Participation
Yoga group
(n¼19)
Walking group
(n¼15)
Factor Mean SD Mean SD tdfp
Age 23.9 3.0 25.6 4.9 1.25 32 0.22
Female 11 (58%) 11 (73%) – – 0.48
Single 18 (95%) 12 (80%) – – 0.30
Years of education 16.4 1.1 16.7 1.4 0.74 32 0.46
Possible drinking days 91.6 6.9 89.3 15.8 0.56 32 0.58
Actual drinking days 14.8 15.5 8.7 7.4 1.41 32 0.17
Heavy drinking days 0.4 0.6 0.4 0.7 0.09 32 0.93
Very heavy drinking days 0.0 0.0 0.0 0.0 – 32 –
Total drinks 23.8 22.4 13.9 11.3 1.57 32 0.13
Average drinks/possible drinking days 0.3 0.2 0.2 0.1 1.41 32 0.17
Height (m) 1.7 0.1 1.7 0.1 2.43 32 0.02
Weight (kg) 68.2 12.5 65.6 10.9 0.64 32 0.53
Body–mass index 22.5 2.9 23.8 2.7 1.33 32 0.19
PARs (during 12-week intervention) 11.3 10.6 24.8 22.90 2.35 32 0.02
PARs week prior to scan 2 8.5 16.1 19.5 24.9 1.57 32 0.13
Attendance (of 36) 23.4 7.5 24.8 6.2 0.59 32 0.56
Home yoga sessions/week 0.9 1.0
SD, standard deviation; df, degrees of freedom; PAR, Physical Activity Recall.
Table 2. Generalized Estimated Equations Analysis of Mood and Anxiety Scales During Interventions
Yoga group Walking group Difference
beta zpbeta zpbeta zp
EIFI-Positive Engagement 0.792 2.50 0.01 0.450 0.93 0.35 1.424 2.58 0.01
EIFI-Revitalization 3.069 4.46 <0.001 1.771 2.01 0.04 2.359 2.15 0.03
EIFI-Tranquility 1.923 3.10 0.002 0.226 0.28 0.78 2.394 2.42 0.02
EIFI-Physical Exhaustion 1.343 1.86 0.06 0.931 0.99 0.32 2.275 1.95 0.05
STAI-State 4.517 2.11 0.04 2.415 1.05 0.30 6.088 1.93 0.05
EIFI, Exercise-Induced Feeling Inventory; STAI, State–Trait Anxiety Inventory.
4 STREETER ET AL.
Table 3. Tonic and Acute Changes in Thalamic Gamma-Aminobutyric Acid Levels
Tonic Scan 1 Scan 2 (Scan 2–Scan 1) tdfp
Yoga group 0.065 0.020 0.061 0.021 0.004 0.017 1.01 18 0.33
Walking group 0.059 0.023 0.060 0.014 0.000 0.020 0.04 14 0.97
Acute Scan 2 Scan 3 (Scan 3–Scan 2) tdfp
Yoga group 0.058 0.018 0.067 0.019 0.009 0.020 1.80 17 0.09
Walking group 0.060 0.014 0.059 0.019 0.000 0.017 0.10 14 0.92
df, degrees of freedom.
FIG. 2. Spectral data show-
ing an increase in the area of
the edited g-aminobutyric acid
(GABA) resonance doublet at
3.00 parts per million (ppm)
from scan 2 to scan 3 for the
left thalamic voxel in the yoga
group. Glx, glutamate and
glutamine complex; MRS,
magnetic resonance spectros-
copy; NAA, N-acetylaspartate;
MM, macromolecules.
Table 4. Significant Correlations of Thalamic Gamma-Aminobutyric Acid Levels with Mood and Anxiety Scores
Scan(s) rho tdfp
Correlation of thalamic GABA levels with mood and anxiety scores
Whole group
Revitalization 1 0.38 2.32 32 0.03
Tranquility 1 0.50 3.27 32 0.003
Tranquility 2 0.47 3.01 32 0.005
STAI-S 2 0.35 2.11 32 0.04
STAI-S 3 0.41 2.46 30 0.01
Correlation of changes in thalamic GABA levels with changes in mood and anxiety scores
Yoga group
Revitalization 2-1 0.78 5.14 17 0.001
Tranquility 2-1 0.50 2.38 17 0.03
STAI-S 2-1 0.50 2.38 17 0.03
Tranquility 3-2 0.56 2.70 16 0.01
GABA, g-aminobutyric acid; df, degrees of freedom; STAI, State–Trait Anxiety, Inventory.
5
with dropouts equally divided between interventions (Table 1).
The means for the weekly PAR METs during the 12-week
intervention showed the walking group to have a signifi-
cantly greater level of activity outside the intervention than
the yoga group ( p¼0.02); however, there was no difference
between groups in activity levels on the week before Imaging
Session II. Out of 36 sessions, each group attended about two
thirds, with the yoga group reporting about one session a
week at home.
Analysis of mood and anxiety scales and GABA levels
The following analyses were done with statistically sig-
nificant findings reported in the tables: (1) a GEE model for
changes in mood and anxiety scores for each group at weeks
0, 4, 8, and 12; (2) tonic changes in GABA levels were as-
sessed over the course of the intervention by subtracting
Scan 1 from Scan 2 values, while acute changes associated
with the intrascan session were assessed by subtracting Scan
2 from Scan 3 values; (3) tonic and acute changes in GABA
levels; (4) correlations of mood and anxiety scores with
GABA levels for each scan; (5) correlations of tonic (Scan 2–1)
and acute (Scan 3–2) changes in mood and anxiety scores
with tonic and acute changes in GABA levels.
In the three ‘‘positive’’ subscales of EIFI (Positive En-
gagement, Revitalization, and Tranquility), an increase in
score indicates improved mood. In the two ‘‘negative’’ scales,
the STAI-State and EIFI-Physical Exhaustion, an increase in
score indicates increased anxiety and physical exhaustion,
respectively. Inverse associations (-beta), with the negative
scales, indicate decreased anxiety in the within-group anal-
ysis and greater decrease in anxiety for the yoga group in the
between-group analysis.
In the GEE analysis, the yoga group showed increased
scores over the course of the intervention in the three positive
EIFI subscales (Positive Engagement, Revitalization, and
Tranquility), while the walking group showed an increase in
the EIFI-Revitalization subscale. The yoga group showed a
decrease in the STAI-State score, indicating decreased anxi-
ety. The between-group analysis showed the yoga group to
have greater increases in all positive scales and greater de-
creases in all negative scales compared with the walking
group, indicating improved mood, decreased anxiety and
decreased exhaustion (Table 2).
Tonic changes in mean mood scores showed significant
increases in the yoga group for Revitalization (1.8 2.5,
t¼3.21, df ¼18, p¼0.005). Acute changes in mean scores
indicated significant increases in the yoga group for Re-
vitalization (2.5 2.7, t¼4.12, df ¼18, p<0.001) and Tran-
quility (2.0 1.8, t¼4.77, df ¼18, p<0.001), and significant
decrease in the STAI-State (5.2 5.5, t¼4.05, df ¼17,
p<0.001). There were no significant tonic or acute changes
detected in the walking group.
Analysis of the gray matter/white matter ratio in the
thalamic voxel was done for each of the three scans. There
was no difference in the average gray matter/white matter
ratio among the three scans for the thalamus (F¼0.11, df ¼2,
p¼0.90), indicating consistent repositioning of the voxel
over the same anatomical region for each scan. There was no
difference between the yoga and walking group in baseline
GABA levels (t¼0.73, df ¼32, p¼0.47). There were no sig-
nificant changes in tonic GABA levels in either group. There
was a nearly significant increase in acute thalamic GABA
levels in the yoga group (0.009 0.019, t¼1.80, df ¼17,
p¼0.09) (Fig. 2 and Table 3).
Whether thalamic GABA levels correlate with improved
mood or decreased anxiety is a general question, indepen-
dent of group assignment. Therefore, the correlation of mood
and anxiety scores with GABA levels was done for the whole
group. There were significant positive correlations of GABA
levels with Revitalization and Tranquility scores and a neg-
ative correlation with the STAI-State scores (Table 4).
In the yoga group, for the tonic condition, there were
positive correlations of changes in mood and anxiety scores
with changes in mean GABA levels for Revitalization and
Tranquility scores and a negative correlation with the STAI-
State, while in the acute condition there were positive cor-
relations with Tranquility scores (Table 4).
Women (n¼22) used an approved method of birth control
and had negative urine pregnancy tests prior to each imag-
ing session. Because decreases in GABA levels occur during
the follicular phase, women were scheduled for scanning in
the nonluteal stage defined by a serum progesterone
<3.0 ng/mL.
27
All women, except 1 using hormonal con-
traception and assumed to be in the nonluteal stage, had
progesterone levels drawn before each imaging session.
Serum progesterone levels were <2.0 ng/mL for all but four
samples. Two (2) women had levels <5.2 ng/mL for imaging
session I. For imaging session II, serum progesterone levels
were 20.2 ng/mL for 1 subject in the walking group, and
17.3 ng/mL for one subject in the yoga group, consistent
with the luteal phase that is associated with higher GABA
levels. Increases in GABA levels due to the luteal phase
during imaging session II would have made tonic increases
easier to detect, yet there was no significant increase in tonic
GABA levels for either group. In the previous study, in the
yoga group, menstrual stage did not affect increases in
GABA levels. Accordingly, the luteal levels of progesterone
for imaging session II should not have affected the detection
of acute changes.
Discussion
In this study, the yoga intervention was associated with
greater improvements in mood and decreases in anxiety in
the tonic, acute and intervention analyses compared to the
metabolically matched walking intervention, suggesting that
the effect of yoga on mood and anxiety is not solely due to
the metabolic demands of the activity. In our prior study,
significant acute increases in brain GABA levels immediately
after a yoga session were recorded. The current study found
near-significant acute increases, but stable tonic levels during
the 12-week yoga intervention. These observations are con-
sistent with a time-limited effect of the yoga intervention on
thalamic GABA levels. The lack of tonic changes in this
study, and the lack of baseline differences between the ex-
perienced yoga practitioners and controls in the prior study,
suggest that tonic GABA levels are stable in subjects
screened to exclude low GABA states.
The whole group analysis of the correlations between
mood and anxiety scales taken before each scan and the
GABA levels obtained from those scans demonstrated sig-
nificant positive correlations with the positive scales of
Tranquility and Revitalization and a negative correlation
6 STREETER ET AL.
with the STAI-State. To our knowledge, this is the first study
to report a positive correlation between thalamic GABA levels
and improved mood or decreased anxiety. The correlations
between group changes in mood and anxiety scores and
changes in GABA levels in the tonic and acute conditions
suggestthatincreasesinthalamic GABA levels are associated
with improved mood and decreased anxiety. This is the first
study to show that a behavioral intervention (i.e., yoga) is as-
sociated with a positive correlation between changes in tha-
lamic GABA levels and improvements in mood and anxiety.
The use of METs controlled for metabolic demands of each
intervention and allowed the activity level of the 2 groups
(outside of the intervention) to be compared. The signifi-
cantly greater level of physical activity outside the inter-
vention in the walking group compared to the yoga group
was not expected. The higher level of outside activity in the
walking group could have contributed to the finding of
smaller changes in mood and anxiety in the walking group,
as the intervention may not have been a great enough
physical challenge given the greater level of outside activity.
The small sample size in the yoga group where only a
nearly significant increase in thalamic GABA levels was de-
tected was a limitation, which was offset by the findings of
significant correlations between GABA levels and mood and
anxiety scores. In our previous study, the acute increase in
whole-slab GABA levels in experienced yoga practitioners
was 27% (published) and a 26% increase in thalamic GABA
levels (unpublished), compared to a 13% thalamic increase
seen in the current study of yoga-naı
¨ve subjects who were
trained for 12 weeks.
8
This suggests that while subjects can
be trained to practice yoga in a relatively short time with a
measurable effect, the associated change in GABA levels may
increase with experience.
TheeffectoftheyogainterventiononGABAlevelsmay
be due to the ability of yoga practices to increase para-
sympathetic nervous system (PNS) activity.
28–30
In a study
comparing Iyengar yoga to a walking control, the Iyengar
yoga group showed greater increases in PNS activity.
31
Yoga techniques and vagal nerve stimulation (VNS) in-
crease PNS tone by stimulating vagal afferents.
1,32
Studies
suggest that the antiepileptic effects of VNS are largely
mediated by widespread release of GABA.
33
Accordingly,
the practice of yoga through stimulation of vagal afferents
may result in the increase of brain GABA levels as seen
in the yoga group.
Conclusions
The 12-week yoga intervention was associated with
greater improvements in mood and anxiety than a meta-
bolically matched walking exercise. This is the first study to
demonstrate that increased thalamic GABA levels are asso-
ciated improved mood and decreased anxiety. It is also the
first time that yoga postures have been associated with a
positive correlation between acute increases in thalamic
GABA levels and improvements in mean scores on mood
and anxiety scales. Given that pharmacologic agents that
increase the activity of the GABA system are prescribed to
improve mood and decrease anxiety, the reported correla-
tions are in the expected direction.
34,35
The possible role of
GABA in mediating the beneficial effects of yoga on mood
and anxiety warrants further study.
Acknowledgments
We acknowledge the certified Iyengar yoga teachers with-
out whom this project would not have been possible: Marysia
Gensler, Annie Hoffman, Nancy Turnquist, and Lynnae Le-
Blanc. Funding for this study was provided through NIH
grants: 1R21AT004015 (CCS), DAO15116 (PFR), R01 1AA
015923 (DAC), M01RR00533 and Ul1RR025771 (General
Clinical Research Unit at Boston University Medical Center).
Disclosure Statement
Dr. Renshaw is a consultant for Novartis, Roche and Kyowa
Hakko and received research support from GlaxoSmithKline
and Roche. Dr. Ciraulo is a consultant for Novo Nordisk and
received research support from Merck and Catalyst.
References
1. Khalsa S. Yoga as a therapeutic intervention: A bibliometric
analysis of published research studies. Indian J Physiol
Pharmacol 2004;48:269–285.
2. Craft LL, Landers DM. The effect of exercise on clinical de-
pression and depression resulting from mental illness: A
meta-analysis. J Sport Exercise Psychol 1998;20:339–357.
3. Yardi N. Yoga for control of epilepsy. Seizure 2001;10:7–12.
4. Brambilla P, Perez J, Barale F, et al. GABAergic dysfunction
in mood disorders. Mol Psychiatry 2003;8:721–737.
5. Houser CR. GABA neurons in seizure disorders: A review
of immunocytochemical studies. Neurochem Res 1991;16:
295–308.
6. Breier A, Paul S. The GABAa/benzodiazepine receptor:
Implications for the molecular basis of anxiety. J Psychiatr
Res 1990;24:91–104.
7. Schatzberg AF, Nemeroff C. Textbook of Psychopharma-
cology. 2nd ed. Washington, DC: American Psychiatric
Press, 1998.
8. Streeter CC, Jensen JE, Perlmutter RM, et al. Yoga Asana
sessions increase brain GABA levels: A pilot study. J Altern
Complement Med 2007;13:419–426.
9. Jorm AF, Christensen H, Griffiths KM, et al. Effectiveness of
complementary and self-help treatments for depression.
Med J Aust 2002;176(suppl):S84–S96.
10. Jorm AF, Christensen H, Griffiths KM, et al. Effectiveness of
complementary and self-help treatments for anxiety disor-
ders. Med J Aust 2004;181(7 suppl):S29–S46.
11. Lawlor D, Hopker S. The effectiveness of exercise as an in-
tervention in the management of depression: Systematic
review and meta-regression analysis of randomised con-
trolled trials. BMJ 2001;322:763–767.
12. Amin Z, Canli T, Epperson CN. Effect of estrogen–serotonin
interactions on mood and cognition. Behav Cogn Neurosci
Rev 2005;4:43–58.
13. First MB, Gibbon M, Spitzer R, et al. Structured Clinical
Interview for DSM-IV Axis I Disorders, Research Version,
Non-patient Edition (SCID-I/NP). New York: New York
State Psychiatric Institute, 1997.
14. Sobell L, Sobell M. Timeline follow-back: A technique for
assessing self-reported alcohol consumption. In: Litten R,
Allen J, eds. Measuring Alcohol Consumption. Totowa, NJ:
Humana Press, 1992.
15. Watson D, Clark L, Tellegen A. Development and validation
of brief meaures of positive and negative affect: The PANAN
scales. J Pers Soc Psychol 1988;54:1063–1070.
EFFECTS OF YOGA ON MOOD, ANXIETY, AND GABA LEVELS 7
16. Gauvin L, Rejeski WJ. The exercise-induced feeling inven-
tory: Development & initial validation. J Sport Exercise
Psychol 1993;15:403–423.
17. Spielberger CD, Gorsuch RL, Lushene R, et al. Manual for
the State–Trait Anxiety Inventory (Form Y). Redwood City:
Mind Garden, 1983.
18. Ainsworth BE, Haskell WL, Whitt MC, et al. Compendium
of physical activities: An update of activity codes and MET
intensities. Med Sci Sports Exerc 2000;32(9 suppl):S498–S504.
19. Blair S, Applegate W, Dunn A, et al. Activity Counseling
Trail (ACT): Rationale, design, and methods. Med Sci Sport
Exercise 1998;30:1097–1106.
20. Blair S, Haskell W, Ho P, et al. Assessment of habitual physical
activity by seven-day recall in a community survey and con-
trolled experiments. Am J Epidemiol 1985;122:794–804.
21. Silva M, Mehta S. Yoga: The Iyengar Way. New York: Alfred
A. Knopf, 2001.
22. Craig AD. Interoception and Emotion. In: Lewis M, Havi-
land-Jones JM, Barrett LF, eds. Handbook of Emotions, 3rd
ed. New York: The Guilford Press, 2008:272–288.
23. Geuze E, van Berckel BN, Lammertsma AA, et al. Reduced
GABA benzodiazepine receptor binding in veterans with
post-traumatic stress disorder. Mol Psychiatry 2008;13:74–83.
24. Mescher M, Merkle H, Kirsch J, et al. Simultaneous in vivo
spectral editing and water suppression. NMR Biomed
1998;11:266–272.
25. Liang KY, Zeger SL. Longitudinal data analysis using gen-
eralized linear models. Biometrika 1986;73:13–22.
26. Zeger SL, Liang KY. Longitudinal data analysis for discrete
and continuous outcomes. Biometrics 1986;42:121–130.
27. Epperson CN, Haga K, Mason GF, et al. Cortical gamma-
aminobutyric acid levels across the menstrual cycle in
healthy women and those with premenstrual dysphoric
disorder: A proton magnetic resonance spectroscopy study.
Arch Gen Psychiatry 2002;59:851–858.
28. Lee MS, Huh HJ, Kim BG, et al. Effects of Qi-training on
heart rate variability. Am J Chin Med 2002;30:463–470.
29. Elliott R, Rubinsztein JS, Sahakian BJ, et al. The neural basis
of mood-congruent processing biases in depression. Arch
Gen Psychiatry 2002;59:597–604.
30. Elliot S, Edmonson D. The New Science of Breath. 2nd ed.
Allen, TX: Coherence Press, 2006.
31. Khattab K, Khattab AA, Ortak J, et al. Iyengar yoga increases
cardiac parasympathetic nervous modulation among heal-
thy yoga practitioners. Evid Based Complement Alternat
Med 2007;4:511–517.
32. Nemeroff CB, Mayberg HS, Krahl SE, et al. VNS therapy in
treatment-resistant depression: Clinical evidence and puta-
tive neurobiological mechanisms. Neuropsychopharmacol-
ogy 2006;31:1345–1355.
33. Woodbury DM, Woodbury JW. Effects of vagal stimulation
on experimentally induced seizures in rats. Epilepsia
1990;31(suppl 2):S7–S19.
34. Sanacora G, Mason GF, Rothman DL, et al. Increased oc-
cipital cortex GABA concentrations in depressed patients
after therapy with selective serotonin reuptake inhibitors.
Am J Psychiatry 2002;159:663–665.
35. Sanacora G, Mason GF, Rothman DL, et al. Increased cortical
GABA concentrations in depressed patients receiving ECT.
Am J Psychiatry 2003;160:577–579.
Address correspondence to:
Chris C. Streeter, MD
Division of Psychiatry
Boston University School of Medicine
85 East Newton Street, M912-E
Boston, MA 02118
E-mail: streeter@bu.edu
8 STREETER ET AL.
